Study EV-103: Durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rosenberg, JE; Flaig, TW; Friedlander, TW; Milowsky, MI; Srinivas, S; Petrylak, DP; Merchan, JR; Bilen, MA; Carret, A-S; Yuan, N; Sasse, C; Hoimes, CJ

Published Date

  • May 20, 2020

Published In

Volume / Issue

  • 38 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X